Evidence map›Paper›PMID 41193674›Full record

ArticleMolecular psychiatry2026

Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.

Josh Allen, Mujun Sun, Tamara L Baker, Shannon Dames, Pamela Kryskow, Brian R Christie, Stuart J McDonald, Sandy R Shultz

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Psilocybin restores behavior and 5-HTCell reports. Medicine · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Josh AllenDepartment of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.
Mujun SunDepartment of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.
Tamara L BakerDepartment of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.
Shannon DamesPsychedelic-Assisted Therapy Post-Graduate Program, Health Sciences and Human Services, Vancouver Island University, Nanaimo, BC, Canada.ORCID http://orcid.org/0000-0003-1609-4243
Pamela KryskowPsychedelic-Assisted Therapy Post-Graduate Program, Health Sciences and Human Services, Vancouver Island University, Nanaimo, BC, Canada.ORCID http://orcid.org/0000-0003-0310-0368
Brian R ChristieDivision of Medical Sciences, University of Victoria, Victoria, B.C., Canada.ORCID http://orcid.org/0000-0002-6830-0160
Stuart J McDonaldDepartment of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.
Sandy R ShultzDepartment of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia. sandy.shultz@monash.edu.ORCID http://orcid.org/0000-0002-2525-8775

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intimate partner violence (IPV) poses a significant medical concern, predominantly affecting females. IPV-related brain injuries (IPV-BI), such as mild traumatic brain injury (mTBI) and non-fatal strangulation (NFS), sustained during physical attacks are common and often repetitive. Chronic neurobehavioral sequalae from IPV-BI are associated with neuroinflammation and impaired neuroplasticity, and effective treatment options are scarce, particularly in the context of IPV. However, psilocybin, a 5-HT

Indexed as

Intimate Partner ViolencePsilocybinAnimalsBehavior, AnimalBrainBrain ConcussionCognitionDisease Models, AnimalFemaleRatsRats, Sprague-DawleyPsilocybin

Identifiers

PMID41193674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.